Luoxin Pharmaceutical(002793.SZ)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
Luoxin Pharmaceutical
002793.SZ
Luoxin Pharmaceuticals Group Stock Co., Ltd. engages in the research and development, manufacture, and trading of drugs in China. The company provides antiviral, anti-infective, respiratory and digestive system, nervous and endocrine system, cardiovascular system, oncology, and anti-allergic APIs and intermediates, as well as antipyretic, analgesics, and anti-inflammatory APIs and intermediates. It also offers health care services.
2.805 T
002793.SZMarket value -Rank by Market Cap -/-

Financial Score

19/05/2026 Update
D
PharmaceuticalsIndustry
Industry Ranking192/215
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-21.65%E
    • Profit Margin-11.38%D
    • Gross Margin61.01%A
  • Growth ScoreD
    • Revenue YoY-2.78%D
    • Net Profit YoY70.74%A
    • Total Assets YoY-12.64%E
    • Net Assets YoY-20.15%E
  • Cash ScoreD
    • Cash Flow Margin-88.20%E
    • OCF YoY-2.78%D
  • Operating ScoreB
    • Turnover0.62B
  • Debt ScoreD
    • Gearing Ratio67.07%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    A-share Three Major Indices Fell Collectively, Computing Hardware Active Against the Trend, Hang Seng Tech Index Down Over 1%, AI Large Model Stocks Rebound, KNOWLEDGE ATLAS Rises 7%

    Wallstreetcn·
    HK
    02513
    -9.41%
    SZ
    002793
    -5.84%
    SZ
    002589
    +0.99%
    Wallstreetcn·
    HK
    02513
    -9.41%
    SZ
    002793
    -5.84%
    SZ
    002589
    +0.99%

    Luoxin Pharmaceutical: The controlling shareholder has partially lifted the pledge of shares and re-pledged them

    Zhitong·
    SZ
    002793
    -5.84%
    Zhitong·
    SZ
    002793
    -5.84%

    Luoxin Pharmaceutical: Net profit in the third quarter was 5.2318 million yuan, a year-on-year increase of 102.96%

    Zhitong·
    SZ
    002793
    -5.84%
    Zhitong·
    SZ
    002793
    -5.84%

    The concept of innovative drugs continues to rebound, with GZBL and Luoxin Pharmaceutical both hitting the daily limit

    Zhitong·
    SZ
    002793
    -5.84%
    SZ
    002424
    +1.23%
    Zhitong·
    SZ
    002793
    -5.84%
    SZ
    002424
    +1.23%

    Luoxin Pharmaceutical issued a profit warning, expecting a net profit attributable to the parent company of 22.7 million to 25.2 million yuan in the first three quarters, turning losses into profits

    Zhitong·
    SZ
    002793
    -5.84%
    Zhitong·
    SZ
    002793
    -5.84%
    © 2026 Longbridge｜Disclaimer